Compile Data Set for Download or QSAR
maximum 50k data
Found 785 Enz. Inhib. hit(s) with all data for entry = 9039
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436666(6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...)
Affinity DataKi: <100nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436666(6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...)
Affinity DataKi: <100nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436625((S)-6-(2-fluoro-4-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi: <100nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436318(2-(ethylamino)-9- methyl-6-(3-(5-methyl- 1,3,4-oxa...)
Affinity DataKi: <100nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436621((S)-2-methoxy-9- methyl-6-(2-methyl- 4-(3-(methyla...)
Affinity DataKi: <100nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436666(6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...)
Affinity DataKi: <100nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436599((S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- ...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436599((S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- ...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436576((S)-2-amino-9-methyl- 6-(3-(3-(methylamino)- 1-(th...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436584((R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiop...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436588((S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436513(2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436513(2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436528((S)-8-amino-1-methyl-4- (3-(3-(methylamino)-1- (th...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436528((S)-8-amino-1-methyl-4- (3-(3-(methylamino)-1- (th...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436529((S)-8-amino-1-methyl- 4-(4-(3-(methylamino)- 1-(th...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436529((S)-8-amino-1-methyl- 4-(4-(3-(methylamino)- 1-(th...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436531(1,8-dimethyl-4-(3-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436531(1,8-dimethyl-4-(3-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436532((S)-1,8-dimethyl-4-(4- (3-(methylamino)-1- (thioph...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436532((S)-1,8-dimethyl-4-(4- (3-(methylamino)-1- (thioph...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436547(1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436547(1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436549((S)-8-(ethylamino)-1- methyl-4-(3-(3- (methylamino...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436549((S)-8-(ethylamino)-1- methyl-4-(3-(3- (methylamino...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436550((S)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436550((S)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436551((R)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436551((R)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436555((S)-8-methoxy-1- methyl-4-(3-(3- (methylamino)-1- ...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436555((S)-8-methoxy-1- methyl-4-(3-(3- (methylamino)-1- ...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436565((R)-9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436565((R)-9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)...)
Affinity DataKi:  300nMAssay Description:NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436566((R)-9-methyl-2- (methyl(pyridin-3- ylmethyl)amino)...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436599((S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- ...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436603((S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436605(1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436606((S)-1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436607((S)-8-(ethylamino)-1- methyl-4-(4-(3- (methylamino...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436608((S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methyla...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436609((S)-8-methoxy-1- methyl-4-(4-(3- (methylamino)-1- ...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436610((S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436611(2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thi...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436613((S)-1-ethyl-8- methoxy-4-(4-(3- (methylamino)-1- (...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436614(2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thi...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436615((S)-1-ethyl-4-(4-(3- (methylamino)-1- (thiophen-2-...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436616(2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(5- m...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436617((S)-2-methoxy-9- methyl-6-(3-methyl- 4-(3-(methyla...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436618((S)-6-(3-fluoro-4-(3- (methylamino)-1- (thiophen-2...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103](Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM436619((S)-9-ethyl-2- methoxy-6-(4-(3- (methylamino)-1- (...)
Affinity DataKi:  300nMAssay Description:α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 785 total ) | Next | Last >>
Jump to: